BCRX · Biocryst Pharmaceuticals Inc
$9.87
+0.04 (+0.41%)
At close · Aug 27
Market Cap
$2.51B
Shares
255.54M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K/A | 2026-08-04 | 2026-06-25 | |
| 8-K | 2026-06-29 | 2026-06-25 | |
| 8-K | 2026-06-12 | 2026-06-11 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-06 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-04 | — | |
| DEF 14A | 2026-04-23 | 2026-06-11 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K/A | 2026-01-23 | 2025-10-14 | |
| 8-K | 2026-01-23 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2025-12-12 | — | |
| 8-K | 2025-12-11 | 2025-12-09 | |
| 8-K | 2025-12-03 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-10-01 | — | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-07-31 | 2025-07-25 | |
| 8-K | 2025-07-07 | — | |
| 8-K | 2025-06-30 | 2025-06-27 | |
| 8-K | 2025-06-27 | — | |
| 8-K | 2025-06-25 | 2025-06-23 | |
| 8-K | 2025-06-16 | 2025-06-11 | |
| 8-K | 2025-06-04 | 2025-05-31 | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-05 | — | |
| 8-K | 2025-05-01 | 2025-04-30 | |
| DEF 14A | 2025-04-24 | 2025-06-12 | |
| 8-K | 2025-04-10 | 2025-04-06 | |
| 8-K | 2025-03-11 | 2025-03-10 | |
| 8-K | 2025-03-04 | 2025-02-28 | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2025-02-24 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2025-01-08 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-10-02 | — | |
| 8-K | 2024-09-30 | — |
Showing 1–50 of 160 filings
Key facts
CIK
882796
CUSIP
09058V103
13F (30d)
278 filings
275 filers
Visit website
Investor relations